Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Subklewe

Showing results (61-70 of 244) with videos related to

Pageof 25
Sort By:
Biomarker Research|June 10, 2022
Integrated multiomic approach for identification of novel immunotherapeutic targets in AMLThomas Köhnke, Xilong Liu, Sascha Haubner, et al.
Imaging Neuroscience (Cambridge, Mass.)|November 5, 2025
Denoising strategies of functional connectivity MRI data in lesional and non-lesional brain diseasesStephan Wunderlich, Cagatay Alici, Saeed Motevalli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 21, 2020
Transformation of diffuse large B cell lymphoma into dendritic sarcoma under CAR T cell therapy detected on <sup>18</sup>F-FDG PET/CTMichael Winkelmann, Kai Rejeski, Marcus Unterrainer, et al.
Journal of Hematology & Oncology|July 30, 2015
T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartmentFrauke M Schnorfeil, Felix S Lichtenegger, Katharina Emmerig, et al.
Human Immunology|December 20, 2005
Dendritic cells expand Epstein Barr virus specific CD8+ T cell responses more efficiently than EBV transformed B cellsMarion Subklewe, Kathrin Sebelin, Andrea Block, et al.
Oncotarget|January 7, 2017
SIRPα-antibody fusion proteins stimulate phagocytosis and promote elimination of acute myeloid leukemia cellsLaia Pascual Ponce, Nadja C Fenn, Nadine Moritz, et al.
Bone Marrow Research|May 27, 2014
Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of HeterozygosityKlaus Witter, Roland Reibke, Marion Subklewe, et al.
Frontiers in Immunology|March 15, 2018
Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting CellsFelix S Lichtenegger, Maurine Rothe, Frauke M Schnorfeil, et al.
Hemasphere|May 1, 2023
An International Survey on Grading, Diagnosis, and Management of Immune Effector Cell-Associated Hematotoxicity (ICAHT) Following CAR T-cell Therapy on Behalf of the EBMT and EHAKai Rejeski, Raffaella Greco, Francesco Onida, et al.
Cancer|May 14, 2020
The BiTE (bispecific T-cell engager) platform: Development and future potential of a targeted immuno-oncology therapy across tumor typesHermann Einsele, Hossein Borghaei, Robert Z Orlowski, et al.
Pageof 25

Showing results (61-70 of 244) with videos related to

Sort By:
Pageof 25
Biomarker Research|June 10, 2022
Integrated multiomic approach for identification of novel immunotherapeutic targets in AMLThomas Köhnke, Xilong Liu, Sascha Haubner, et al.
Imaging Neuroscience (Cambridge, Mass.)|November 5, 2025
Denoising strategies of functional connectivity MRI data in lesional and non-lesional brain diseasesStephan Wunderlich, Cagatay Alici, Saeed Motevalli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 21, 2020
Transformation of diffuse large B cell lymphoma into dendritic sarcoma under CAR T cell therapy detected on <sup>18</sup>F-FDG PET/CTMichael Winkelmann, Kai Rejeski, Marcus Unterrainer, et al.
Journal of Hematology & Oncology|July 30, 2015
T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartmentFrauke M Schnorfeil, Felix S Lichtenegger, Katharina Emmerig, et al.
Human Immunology|December 20, 2005
Dendritic cells expand Epstein Barr virus specific CD8+ T cell responses more efficiently than EBV transformed B cellsMarion Subklewe, Kathrin Sebelin, Andrea Block, et al.
Oncotarget|January 7, 2017
SIRPα-antibody fusion proteins stimulate phagocytosis and promote elimination of acute myeloid leukemia cellsLaia Pascual Ponce, Nadja C Fenn, Nadine Moritz, et al.
Bone Marrow Research|May 27, 2014
Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of HeterozygosityKlaus Witter, Roland Reibke, Marion Subklewe, et al.
Frontiers in Immunology|March 15, 2018
Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting CellsFelix S Lichtenegger, Maurine Rothe, Frauke M Schnorfeil, et al.
Hemasphere|May 1, 2023
An International Survey on Grading, Diagnosis, and Management of Immune Effector Cell-Associated Hematotoxicity (ICAHT) Following CAR T-cell Therapy on Behalf of the EBMT and EHAKai Rejeski, Raffaella Greco, Francesco Onida, et al.
Cancer|May 14, 2020
The BiTE (bispecific T-cell engager) platform: Development and future potential of a targeted immuno-oncology therapy across tumor typesHermann Einsele, Hossein Borghaei, Robert Z Orlowski, et al.
Pageof 25